FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:602-606 August 28, 1997 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

The dangers inherent in marked obesity have prompted physicians to advocate more aggressive strategies for weight reduction. One current strategy is the prescription of fenfluramine,^1,2 either alone or in combination with phentermine, with the knowledge that the risks of the drugs must be balanced against the risks of continued obesity.

Pulmonary hypertension in adults has several causes that can be identified pathologically. In the case of pulmonary hypertension that develops with hypoxia during the course of chronic obstructive or interstitial fibrosing disease of the lung, the pulmonary vessels are characterized by intimal and medial hyperplasia and luminal stenosis. Thromboembolic pulmonary . . . [Full Text of this Article]

Case Report

Clinical Findings

Pathological Findings

Discussion

Source Information

From the Department of Pathology, Massachusetts General Hospital, and Harvard Medical School (E.J.M., H.T.C.), and the Office of the Chief Medical Examiner, Commonwealth of Massachusetts (E.J.M., E.D.P., R.J.E., S.C.K.) — all in Boston.

Address reprint requests to Dr. Mark at the Department of Pathology, Massachusetts General Hospital, 55 Fruit St., Warren Bldg. 219, Boston, MA 02114-2696.

References

This article has been cited by other articles:

• 2006 WRITING COMMITTEE MEMBERS, , Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S. (2008). 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118: e523-e661 [Full Text]  
• Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Nishimura, R. A., Carabello, B. A., Faxon, D. P., Freed, M. D., Lytle, B. W., O'Gara, P. T., O'Rourke, R. A., Shah, P. M. (2008). 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52: e1-e142 [Full Text]  
• Borer, J. S., Pouleur, H., Abadie, E., Follath, F., Wittes, J., Pfeffer, M. A., Pitt, B., Zannad, F. (2007). Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval. Eur Heart J 28: 1904-1909 [Abstract] [Full Text]  
• Said, S. I. (2006). Mediators and modulators of pulmonary arterial hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L547-L558 [Abstract] [Full Text]  
• Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B. (2006). ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48: e1-e148 [Full Text]  
• Witzenrath, M., Ahrens, B., Kube, S. M., Hocke, A. C., Rosseau, S., Hamelmann, E., Suttorp, N., Schutte, H. (2006). Allergic lung inflammation induces pulmonary vascular hyperresponsiveness. Eur Respir J 28: 370-377 [Abstract] [Full Text]  
• Lynch, M. J., Burns, R. G., Holcomb, J. E. (2005). Food for Thought: An Investigation of Food and Drug Administration Reporting Practices, 1995-1999. Criminal Justice Review 30: 293-311 [Abstract]  
• Farber, H. W., Loscalzo, J. (2004). Pulmonary Arterial Hypertension. NEJM 351: 1655-1665 [Full Text]  
• Weigle, D. S. (2003). Pharmacological Therapy of Obesity: Past, Present, and Future. J. Clin. Endocrinol. Metab. 88: 2462-2469 [Full Text]  
• Mitani, Y., Mutlu, A., Russell, J. C., Brindley, D. N., DeAlmeida, J., Rabinovitch, M. (2002). Dexfenfluramine protects against pulmonary hypertension in rats. J. Appl. Physiol. 93: 1770-1778 [Abstract] [Full Text]  
• Humbert, M., Deng, Z., Simonneau, G., Barst, R.J., Sitbon, O., Wolf, M., Cuervo, N., Moore, K.J., Hodge, S.E., Knowles, J.A., Morse, J.H. (2002). BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur Respir J 20: 518-523 [Abstract] [Full Text]  
• Tomita, T., Zhao, Q. (2002). Autopsy Findings of Heart and Lungs in a Patient With Primary Pulmonary Hypertension Associated With Use of Fenfluramine and Phentermine. Chest 121: 649-652 [Abstract] [Full Text]  
• Appelbaum, L., Yigla, M., Bendayan, D., Reichart, N., Fink, G., Priel, I., Schwartz, Y., Richman, P., Picard, E., Goldman, S., Kramer, M. R. (2001). Primary Pulmonary Hypertension In Israel : A National Survey. Chest 119: 1801-1806 [Abstract] [Full Text]  
• Archer, S., Rich, S. (2000). Primary Pulmonary Hypertension : A Vascular Biology and Translational Research "Work in Progress". Circulation 102: 2781-2791 [Abstract] [Full Text]  
• YI, E. S., KIM, H., AHN, H., STROTHER, J., MORRIS, T., MASLIAH, E., HANSEN, L. A., PARK, K., FRIEDMAN, P. J. (2000). Distribution of Obstructive Intimal Lesions and Their Cellular Phenotypes in Chronic Pulmonary Hypertension . A Morphometric and Immunohistochemical Study. Am. J. Respir. Crit. Care Med. 162: 1577-1586 [Abstract] [Full Text]  
• Kereveur, A., Callebert, J., Humbert, M., Herve, P., Simonneau, G., Launay, J.-M., Drouet, L. (2000). High Plasma Serotonin Levels in Primary Pulmonary Hypertension : Effect of Long-Term Epoprostenol (Prostacyclin) Therapy. Arterioscler. Thromb. Vasc. Bio. 20: 2233-2239 [Abstract] [Full Text]  
• Rich, S., Rubin, L., Walker, A. M., Schneeweiss, S., Abenhaim, L. (2000). Anorexigens and Pulmonary Hypertension in the United States: Results From the Surveillance of North American Pulmonary Hypertension. Chest 117: 870-874 [Abstract] [Full Text]  
• Bray, G. A., Greenway, F. L. (1999). Current and Potential Drugs for Treatment of Obesity. Endocr. Rev. 20: 805-875 [Abstract] [Full Text]  
• Salvi, S. S. (1999). {alpha}1-Adrenergic Hypothesis for Pulmonary Hypertension. Chest 115: 1708-1719 [Abstract] [Full Text]  
• Grewal, J. S., Mukhin, Y. V., Garnovskaya, M. N., Raymond, J. R., Greene, E. L. (1999). Serotonin 5-HT2A receptor induces TGF-beta 1 expression in mesangial cells via ERK: proliferative and fibrotic signals. Am. J. Physiol. Renal Physiol. 276: F922-F930 [Abstract] [Full Text]  
• Friedman, M. A., Woodcock, J., Lumpkin, M. M., Shuren, J. E., Hass, A. E., Thompson, L. J. (1999). The Safety of Newly Approved Medicines: Do Recent Market Removals Mean There Is a Problem?. JAMA 281: 1728-1734 [Abstract] [Full Text]  
• Wojnicki, F. H. E., Rothman, R. B., Rice, K. C., Glowa, J. R. (1999). Effects of Phentermine on Responding Maintained under Multiple Fixed-Ratio Schedules of Food and Cocaine Presentation in the Rhesus Monkey. J. Pharmacol. Exp. Ther. 288: 550-560 [Abstract] [Full Text]  
• Fishman, A. P. (1999). Aminorex to Fen/Phen : An Epidemic Foretold. Circulation 99: 156-161 [Full Text]  
• TUDER, R. M., RADISAVLJEVIC, Z., SHROYER, K. R., POLAK, J. M., VOELKEL, N. F. (1998). Monoclonal Endothelial Cells in Appetite Suppressant-associated Pulmonary Hypertension. Am. J. Respir. Crit. Care Med. 158: 1999-2001 [Abstract] [Full Text]  
• Haworth, S. G (1998). Primary pulmonary hypertension in childhood. Arch. Dis. Child. 79: 452-455 [Full Text]  
• ARCHER, S. L., DJABALLAH, K., HUMBERT, M., KENNETH WEIR, E., FARTOUKH, M., DALL'AVA-SANTUCCI, J., MERCIER, J.-C., SIMONNEAU, G., TUAN DINH-XUAN, A. (1998). Nitric Oxide Deficiency in Fenfluramine- and Dexfenfluramine-induced Pulmonary Hypertension. Am. J. Respir. Crit. Care Med. 158: 1061-1067 [Abstract] [Full Text]  
• Martin, A., State, M., Koenig, K., Schultz, R., Dykens, E. M., Cassidy, S. B., Leckman, J. F. (1998). Prader-Willi Syndrome. Am. J. Psychiatry 155: 1265-1273 [Full Text]  
• KANEKO, F. T., ARROLIGA, A. C., DWEIK, R. A., COMHAIR, S. A., LASKOWSKI, D., OPPEDISANO, R., THOMASSEN, M. J., ERZURUM, S. C. (1998). Biochemical Reaction Products of Nitric Oxide as Quantitative Markers of Primary Pulmonary Hypertension. Am. J. Respir. Crit. Care Med. 158: 917-923 [Abstract] [Full Text]  
• Kassirer, J. P., Angell, M. (1998). Losing Weight -- An Ill-Fated New Year's Resolution. NEJM 338: 52-54 [Full Text]  
• (1997). Weight Loss Medications: More Lost Than Gained. JWatch Psychiatry 1997: 18-18 [Full Text]  
• (1997). More Reason for Caution with Diet Pills. Journal Watch Cardiology 1997: 2-2 [Full Text]  
• (1997). MORE ON DIET PILLS AND VALVULAR DISEASE. JWatch General 1997: 1-1 [Full Text]  
• Curfman, G. D. (1997). Diet Pills Redux. NEJM 337: 629-630 [Full Text]